Morphosys Ag (MOR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
MorphoSys AG has announced a merger squeeze-out with Novartis BidCo Germany AG offering a cash compensation of EUR 68.00 per share for the transfer of shares from minority shareholders. This action is pending approval at the MorphoSys AG Annual General Meeting and subsequent registrations in commercial registers. The court-appointed expert auditor has preliminarily affirmed the fairness of the compensation amount.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.
